Fig. 2: Complement and cytokine effector proteins in ADEs.

Each point represents the value for one study participant. The mean ± S.E.M. of control (C) and first-episode psychosis (FP) groups, respectively, were 111,641 ± 14,822 pg/ml and 466,335 ± 100,239 pg/ml for GFAP (a); 10,167 ± 994 pg/ml and 117,468 ± 26,305 pg/ml for C3b (b); 330 ± 56.0 pg/ml and 573 ± 100 pg/ml for C5b-9 (c); 49,621 ± 6073 pg/ml and 7652 ± 1452 pg/ml for CD55 (DAF) (d); 1087 ± 299 pg/ml and 613 ± 134 pg/ml for CD59 (e); 44.8 ± 5.35 pg/ml and 45.0 ± 5.85 pg/ml for IL-6 (f); and 1519 + 204 pg/ml and 424 + 64.2 pg/ml for LIF (g). Statistical significance of differences in values between C and FP groups were calculated by two sample t tests; †, p < 0.05; *, p < 0.01; **, p < 0.001.